‘Jury still out’ on best strategy for psoriatic arthritis

The ‘jury is still out’ on the best time to initiate aggressive therapy in patients with psoriatic arthritis, say researchers who carried out a long-term follow-up study on the benefits of early tight disease control. Despite clear advantages shown in patients in a treat-to-target group at 48 weeks, the benefits had not been maintained compared ...

Already a member?

Login to keep reading.

© 2021 the limbic